Evaluation of Tamoxifen and Simvastatin as the Combination Therapy for the Treatment of Hormonal Dependent Breast Cancer cells

In conclusion, our results suggest that SIM may serve as a promising treatment with TAM for improving the efficacy against estrogen receptor-positive (ER+) breast cancer.Graphical abstract
Source: Toxicology Reports - Category: Toxicology Source Type: research